Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of perioperative use of PCSK9 inhibitor evolocumab on prognosis of myocardial infarction patients undergoing percutaneous coronary intervention

Next Previous
Trial Profile

Effect of perioperative use of PCSK9 inhibitor evolocumab on prognosis of myocardial infarction patients undergoing percutaneous coronary intervention

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Mar 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Evolocumab (Primary) ; Angiotensinogen inhibitors; Aspirin; Atorvastatin; Beta adrenergic receptor antagonists; Clopidogrel; Rosuvastatin; Ticagrelor
  • Indications Acute coronary syndromes; Myocardial infarction; Myocardial ischaemia; Stroke
  • Focus Therapeutic Use
  • Acronyms SECURE-PCI

Most Recent Events

  • 27 Feb 2021 Trial design published in the Advances in Therapy
  • 27 Feb 2021 Status changed from not yet recruiting to recruiting, according to Results published in the Advances in Therapy
  • 30 May 2020 Planned number of patients changed from 1396 to 530.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top